ABSTRACT -The present communication deals with information regarding the practice of the oral glucose tolerance test and determination of serum fructosamine in laboratory beagles. In the oral glucose tolerance test, a 180-min level was found to be crucial following a gavage administration of 50% glucose solution at 5 mL/kg per body weight under fasting conditions. Serum fructosamine concentration as determined by enzymatic assay ranged between 82 and 123 µmol/L (mean of 104 µmol/L), which was about 0.285 to 0.25 times the value obtained by the chemical method described by Johnson and colleagues. Reasons for differences are ascribed to the presence of substances with reducing potential other than fructosamine in the serum.
INTRODUCTION
The present communication describes the practice of an oral glucose tolerance test and determination of serum fructosamine level by enzymatic assay in laboratory beagles. In view of the scarcity of such information in the field of toxicity research, these parameters would provide useful information in the study of toxicological insults on the pancreas. The oral glucose tolerance test is a useful tool to detect glucose intolerance in animals with persistent hyperglycemia below the renal threshold (Duncan et al., 1994) . The measurement of serum fructosamine concentration could be an indicator of the disturbance in protein or glucose metabolism (Jensen and Aaes, 1992) . Fructosamine represents glycated serum protein, which reflects the average plasma glucose concentration over 1 to 3 weeks (Meyer and Harvey, 1998) . In the present study, a recently introduced enzymatic assay method (Komiyama et al., 1998) was compared with a traditional chemical method (Johnson et al., 1982) in determining fructosamine levels.
MATERIALS AND METHODS

Animals
Fifteen beagle dogs (10 males and 5 females, HRA beagle, Covance Research Products Inc. Va., U.S.A.) 10 to 33 months of age were used in the study. They were kept in animal rooms under routine controlled conditions, and fed a pellet diet (restricted feeding 300 gr/body/day, DS-A, Oriental yeast Co. Ltd. Tokyo, Japan), and tap water ad libitum.
Methods
Out of 15 animals, 5 males and 5 females were subjected to overnight fasting for about 16 hr prior to the study. Blood samples (5 mL) were then collected and centrifuged. Sera from these animals were analyzed for serum glucose and fructosamine levels. The resulting glucose level was employed as the baseline value of fasting blood glucose in the study. Following blood sampling, an oral glucose tolerance test was performed according to the following procedure: all the animals were given 50% glucose solution at 5 mL/kg bw. by gavage. Blood samples were obtained before treatment as described above, and 30, 60, 90, 120 and 180 min following treatment with glucose solution, and analyzed for glucose concentration. The test was repeated twice at an interval of one week (1 st and 2 nd trials). The remaining 5 males were treated similarly as the above-mentioned ten animals with the exception of the oral glucose tolerance test. Serum samples were obtained from these animals twice at an interval of one week (1 st and 2 nd trials). These serum samples were analyzed for fructosamine concentration via both enzymatic and chemical methods in order to compare both methods.
Plasma glucose concentration was determined by the glucose dehydrogenase method using Cica-liquid GLU (Kanto Kagaku, Co. Tokyo, Japan). Fructosamine levels were determined by the FOD-TOOS method, an enzymatic assay for glycated proteins using Auto-Wako-Fructosamine (Wako Pure Chemical Industries, Ltd. Osaka, Japan) (Komiyama et al., 1998) and via a chemical method described by Johnson et al. (1982) using LiquitechR fructosamine (Roche Diagnostics, Co. Tokyo, Japan). The Model TBA-120FR (Toshiba, Co. Tokyo, Japan), was also employed to determine both parameters.
Presentation of data
The data obtained from these duplicate trials are separately summarized as the individual value, mean, and standard deviation (SD). No statistical analyses were performed. Table 1 shows the transition of serum glucose concentration in the oral glucose tolerance test, and serum fructosamine concentration as determined by enzymatic assay just prior to conducting a glucose tolerance test (individual values, mean ± SD) for two trials, respectively. The mean fasting blood glucose value was 105 mg/dL (range: 100~115 mg/dL) in the first trial and 101 mg/dL (range: 92~113 mg/dL) in the second trial. These values were found to be comparable to the reported reference interval for fasting serum glucose concentration in dogs (77~120 mg/dL) (Meyer and Harvey, 1998) . In the oral glucose tolerance test, the mean glucose concentration reached a maximum (mean and range: 153, 96~257 mg/dL in the first trial, or 141, 101~187 mg/dL in the second trial) 30 min following the glucose overload, after which the values gradually decreased, and reached levels (mean and range: 95, 87~103 mg/dL in the first trial or 94, 87~105 mg/dL in the second trial) comparable to the pre-overload baseline values 180-min after the glucose overload. There were large individual differences up to 120 min after the glucose overload. For example, animal No.10 (Female) exhibited an extremely high blood glucose level up to 90 min following the glucose overload in the first trial, and the animal showed a milder but similar pattern also in the second trial. Conversely, animal Nos. 2, 3, and 9 revealed only a slight response following the glucose overload. These findings certainly reflect the difference in glucose tolerance. However, the glucose values converged on the level of pre-load value 180 min after the glucose overload. As seen in Table 1 , serum glucose levels at various examination points in the second trial were almost comparable to those in the first trial, suggesting the reproducibility of the method. Therefore, the 180-min value was crucial in making a decision of glucose intolerance under the present experimental conditions. These results were shown to be similar to those in a protocol of glucose tolerance in dogs as described in a textbook of veterinary clinical laboratory medicine (Duncan et al., 1994) .
RESULTS AND DISCUSSION
Fructosamine values, determined by enzymatic assay, averaged 109 µmol/L (range: 93~123 µmol/L) in the first trial or 107 µmol/L (range: 98~119 µmol/L) in the second trial. The results obtained were nearly the same in both trials. In determining fructosamine concentration, we employed an enzymatic assay for glycated proteins, different from the known chemical (nitroblue tetrazolium, NBT) method described by Johnson and colleagues (Johnson et al., 1982) . The enzymatic assay employed in this study has been reported to have high specificity for glycated proteins, and the presence of other substances in blood have been shown to not significantly affect the assay (Komiyama et al., 1998) . The fructosamine concentration obtained in the present study was much lower than that determined by the chemical method. For example, the reference interval is 258.6~343.8 µmol/L (Jensen and Aaes, 1992) or 187~386 µmol/L with a median of 312 µmol/L for healthy dogs (Reusch et al., 1993) . To date, there have been no reports dealing with serum fructosamine concentration as determined by the enzymatic method or comparison of the enzymatic and chemical methods for determination of fructosamine concentration in dogs. Due to these circumstances, we tested and compared serum fructosamine concentration using both the enzymatic and chemical methods. In our comparison trial, as shown in Table 2 , fructosamine concentration as determined by the enzy- The table indicates transition of serum glucose concentration (*: mg/dL) following gavage administration of 50% glucose solution at 5 mL/kg b.w.. The mean glucose level reached a maximum 60 min after glucose overload, and returned to pre-dosing levels (PRE) 180 min after glucose overload. Fructosamine concentrations (**: µmol/L) as determined by enzymatic assay are comparable in two independent trials. Sequential change in serum glucose level in oral glucose tolerance test, and fructosamine concentration in nontreated beagles tested twice at an interval of one week. matic assay ranged from 86~108 µmol/L with a mean of 94 µmol/L in the first trial, and 82 to 104 µmol/L with a mean of 93 µmol/L in the second trial. Although there were some differences in these values, fructosamine levels were within a comparable range with those recorded in foregoing trials. Corresponding values as determined by chemical assay ranged from 339~364 µmol/L with a mean of 346 µmol/L in the first trial or 353~402 µmol/L with a mean of 375. The reason for this difference may, in part, be due to differences in the difference in the theory of both assays. The enzymatic method employed was based on specific enzymatic determination of fructosyl lysine using fructosyl lysine oxidase (FOD) (Komiyama et al., 1998) , and the chemical method relied on the ability of ketoamine (fructosamines) to act as a reducing agent under alkaline conditions (Johnson et al., 1982) . Therefore, the latter method was thought to be vulnerable to the presence of any substances with reducing potential.
